Skip to main content

Therapeutic Drug Monitoring: Last Dose, Sample Time and Interpretation

A medicine concentration is interpretable only in its clinical and dosing context. Record the exact medicine and formulation, monitoring purpose, recent actual doses and the actual specimen time. Twelve-hour post-dose sampling is relevant to lithium monitoring, but it is not a universal rule for every medicine level. Preserve deviations and obtain the responsible clinician's interpretation instead of changing a dose from an isolated flagged result.

By Bractis · Updated · 8 min read

Indian OPD teams coordinating lithium, anti-seizure medicine, transplant and other therapeutic drug monitoring with a laboratory or specialist.

State why the medicine level is being measured

Monitoring may address a planned review, a recent change, suspected toxicity, an interaction, uncertain use or loss of clinical control. These questions can require different sampling and interpretation. A request that says only 'drug level' hides the reason the result was needed.

Identify the exact active ingredient, formulation and regimen, including combination or modified-release products. Record the responsible prescribing service, especially when a transplant or specialist team manages treatment and the local clinic is arranging the specimen.

NHS SPS's March 2026 phenytoin monitoring guidance does not recommend routine concentration testing for every stable patient; it lists particular clinical reasons to consider it. That is an indication-specific example, not a reason to omit an already justified test or to create routine monthly levels for all monitored medicines.

Source: NHS SPS: Phenytoin monitoring, updated March 2026

Distinguish a timed post-dose sample from a generic trough

NHS SPS describes lithium concentration sampling at a standardised twelve-hour interval after the last dose. Its tacrolimus guidance instead specifies whole-blood trough measurements in the transplant context. The correct relationship must be established for the actual medicine, formulation and specialist plan.

Do not use 'trough' as a synonym for 'twelve hours' across the catalogue. A pre-next-dose sample depends on the prescribed interval, while a standardised post-dose measurement is defined by its own timing convention. The laboratory should receive the intended sampling relationship and the actual timestamps.

Ask what to do with the next scheduled medicine administration before the patient arrives. The clinic should not improvise a skipped dose or a delayed dose to make the specimen fit. If the plan is unclear, obtain prescriber or specialist instructions rather than borrowing a lithium leaflet for another medicine.

Source: NHS SPS: Lithium monitoring

Source: NHS SPS: Tacrolimus monitoring

Calculate the interval from actual use, not the printed schedule

In a fictional monitoring record, the medicine was scheduled for 21:00 but actually taken at 23:15. Blood was collected at 09:00 the next morning. The actual post-dose interval is nine hours and forty-five minutes, not twelve hours. Copying the scheduled time would conceal a two-hour-fifteen-minute difference.

Preserve the patient's account and its certainty. If the person recalls 'after midnight' but not an exact time, record an approximate time or range as appropriate; do not turn it into 00:00 merely because the field requires a value. The responsible reviewer needs to know the uncertainty.

The interval calculation describes what happened. It does not determine whether the sample is acceptable, how to interpret the concentration or whether to repeat it. Those decisions belong to the laboratory and clinician with the relevant medicine and clinical context.

Send the laboratory more than a medicine name

This original map identifies the facts that help a reviewer interpret the sample. It does not define therapeutic targets or convert results into prescribing advice.

On a narrow screen, scroll the table horizontally to read all columns.

Evidence accompanying a therapeutic drug level
InformationWhy it mattersAvoid
Medicine and formulationConnects the level to the actual product and regimenTreating all formulations as identical
Purpose of monitoringExplains the clinical question and urgencyA routine calendar label hiding suspected toxicity
Recent actual useIdentifies delays, missed doses or recent changesSubstituting the prescribed schedule for reported use
Last dose and specimen timesEstablishes the actual sampling relationshipCalling every level a twelve-hour trough
Specimen and assay detailsPreserves whole blood/serum/plasma and relevant method contextChanging specimen type in a generic request template
Clinical and laboratory contextSupports interpretation with relevant organ function and symptomsTreating a target range as the patient's entire assessment
Result review and planRecords the responsible clinician's decisionAutomatic dose changes from a high/low flag

Keep concentration, reference information and the patient together

A reported range is not an instruction to move every patient into its middle. Retain the laboratory's units and comments and the specialist's target where one has been set. If two reports use different units or assays, establish comparability before drawing a trend.

SPS notes that reduced protein binding can increase unbound phenytoin and that a free concentration may be more appropriate in certain circumstances. This illustrates why an apparently reassuring total concentration cannot be interpreted independently of the patient's context. The guide does not provide a correction equation or dosing adjustment.

Keep relevant clinical observations and other results available to the reviewer. A routine sample collected during an acute illness may answer a different question than the planned stable follow-up. Do not wait for a preferred timed specimen if the patient needs urgent clinical assessment.

Source: NHS SPS: Phenytoin monitoring, updated March 2026

Agree who acts on the result before collecting it

Name the clinician or service interpreting the level and the route for urgent findings. A local clinic drawing blood for a distant specialist should not assume the specialist sees every uploaded PDF. Confirm the accepted handover rather than merely placing the result in a shared inbox.

Record result receipt, review and patient communication separately. If the clinician changes instructions, preserve the authorised version and explain it to the person actually taking or administering the medicine. An outside pharmacy or caregiver may still hold an earlier plan.

Keep repeat sampling linked to the reason for the repeat, such as an uncertain interval or a clinician-selected follow-up. This prevents a second specimen from being mistaken for an unrelated monitoring episode and makes unnecessary duplicate bookings easier to identify.

Use a timing note that can represent uncertainty

The outline below supports both a planned sample and an exception. Unknown use or timing should remain visible; a form that insists on a precise dose time can create false data. The person entering the account should not be mistaken for the clinician who authorised the regimen.

In a local software demonstration, use the fictional late-dose example and an amended last-dose time. Verify that the elapsed interval recalculates without rewriting the original entry, and that no dosing recommendation appears as a consequence. Clinical decision support would require separate evidence and validation.

Fictional example: the appointment was on time but the dose was late

A patient attends at the booked time but reports taking the previous evening's medicine later than planned. The clinic records the actual dose and sample times and alerts the interpreting service to the difference. The specimen is not relabelled to fit the booking. The responsible clinician decides how the result can be used and whether another sample is needed; the clinic does not alter treatment from the timer alone.

Drug Level Timing and Evidence Worksheet

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Clinical question
Why is the level being measured, and who will interpret it?
Sampling relationship
Does the instruction fit the actual medicine, formulation and specimen?
Actual interval
Are dose and specimen times factual, with uncertainty preserved?
Result action
Can you trace the clinician's decision and patient communication separately?

Questions doctors ask

Should every therapeutic drug level be collected twelve hours after a dose?

No. Sampling depends on the medicine, formulation and clinical question. Lithium's standardised post-dose timing must not be copied into every monitoring request.

Which last-dose time matters if the patient took it late?

The actual reported or verified use matters for interpreting the sample. Retain the prescribed schedule separately and calculate the interval from the actual specimen and dose times.

What if the patient cannot remember the exact dose time?

Record the uncertainty and seek the responsible laboratory or clinician's advice. Do not invent a precise timestamp to complete a required field.

Can a high or low concentration automatically change the prescription?

No. The clinician must interpret the level with sampling conditions, clinical status and the applicable target or laboratory information.

Should suspected toxicity wait for a perfectly timed routine sample?

Urgent clinical assessment takes priority. The responsible team decides the investigation and treatment plan; a routine booking convention must not delay care.

Sources and scope

Updated on . This article combines the cited references with Bractis’s original workflow analysis and illustrative examples. Product capabilities depend on the configured scope. No independent clinical or legal review is claimed.

  • NHS SPS: Phenytoin monitoring, updated March 2026

    UK professional guidance on indication-specific monitoring and protein-binding context. No target range, correction formula or treatment change is reproduced.

  • NHS SPS: Lithium monitoring

    UK source for standardised twelve-hour post-dose sampling. Actual patient instructions remain with the responsible prescriber.

  • NHS SPS: Tacrolimus monitoring

    UK transplant monitoring source specifying whole-blood trough measurements. Not a universal sampling interval or target for every formulation.

Try the workflow
with Bractis.

Record a fictional late dose and actual specimen time, revise an uncertain account and preserve the review history without generating an automatic dose change.

Request a clinic demo